“…In the mammalian hippocampus, Kv1.1 and Kv1.4 α subunits are highly expressed in nerve terminals of the perforant path, mossy fiber, and Schaffer collateral pathways (Sheng et al, 1992, Wang et al, 1993, Wang et al, 1994, Maletic-Savatic et al, 1995, Rhodes et al, 1997, Monaghan et al, 2001), while Kv4.2 α subunits and associated KChIPs are expressed at high levels in the dendrites of dentate granule cells, and of CA3 and CA1 pyramidal cells (Sheng et al, 1992, Maletic-Savatic et al, 1995, Varga et al, 2000, Rhodes et al, 2004). Pharmacological blockade of presynaptic Kv1 channels (Bagetta et al, 2004), or genetic ablation of Kv1.1 expression in mice (Smart et al, 1998) is epileptogenic, as is pharmacological blockade of somatodendritic Kv4 channels (Avoli, 2001). Importantly, a recent study shows that the amplitude of backpropagating action potentials is increased in CA1 pyramidal cell dendrites in pilocarpine-induced TLE, suggesting decreased functional expression of dendritic Kv4 channels (Bernard et al, 2004).…”